Shield Therapeutics (STX) RNS Announcements

Add to Alert list
Date Time Source Announcement
04 Aug 2021 04:35 PM
RNS
Price Monitoring Extension
04 Aug 2021 02:05 PM
RNS
Second Price Monitoring Extn
04 Aug 2021 02:00 PM
RNS
Price Monitoring Extension
24 Jun 2021 07:00 AM
RNS
US launch of Accrufer® confirmed for July 1, 2021
23 Jun 2021 04:40 PM
RNS
Second Price Monitoring Extn
23 Jun 2021 04:35 PM
RNS
Price Monitoring Extension
21 Jun 2021 01:35 PM
RNS
Investor presentation
18 Jun 2021 07:00 AM
RNS
Directorate Change
17 Jun 2021 02:30 PM
RNS
Results of 2021 Annual General Meeting
15 Jun 2021 06:15 PM
RNS
Grant of share options to the CEO
28 May 2021 07:00 AM
RNS
Appointment of new Chief Executive Officer
28 May 2021 07:00 AM
RNS
Total Voting Rights
26 May 2021 10:35 AM
EQS
Shield Therapeutics (STX): Accrufer launch on s...
21 May 2021 07:00 AM
RNS
US update
18 May 2021 07:00 AM
RNS
AEGIS-H2H study results published in IBD
17 May 2021 07:00 AM
RNS
Commencement of trading on the OTCQX Best Market
13 May 2021 03:00 PM
RNS
2020 Annual Report and 2021 AGM Notice
10 May 2021 07:00 AM
RNS
Appointment of Two Non-Executive Directors
06 May 2021 01:44 PM
RNS
Total Voting Rights Update
29 Apr 2021 07:00 AM
RNS
Preliminary Results
22 Apr 2021 07:00 AM
RNS
Notice of Results
07 Apr 2021 09:33 AM
RNS
Holding(s) in Company
07 Apr 2021 09:31 AM
RNS
Holding(s) in Company
06 Apr 2021 11:05 AM
RNS
Second Price Monitoring Extn
06 Apr 2021 11:00 AM
RNS
Price Monitoring Extension
06 Apr 2021 07:00 AM
RNS
Holding(s) in Company
31 Mar 2021 03:01 PM
RNS
Total Voting Rights Update
31 Mar 2021 03:00 PM
RNS
Block Listing 6 Monthly Return
30 Mar 2021 07:00 AM
RNS
Investor presentation
26 Mar 2021 07:00 AM
RNS
Study demonstrates effectiveness of ferric maltol
24 Mar 2021 05:40 PM
RNS
Block Listing Application
23 Mar 2021 05:53 PM
RNS
Holding(s) in Company
23 Mar 2021 12:23 PM
RNS
Holding(s) in Company
22 Mar 2021 07:00 AM
RNS
Shield appoints new Chief Financial Officer
18 Mar 2021 02:02 PM
RNS
Result of General Meeting & Open Offer
15 Mar 2021 05:21 PM
RNS
Holding(s) in Company
09 Mar 2021 07:00 AM
RNS
Australia's TGA approves Feraccru
05 Mar 2021 04:54 PM
RNS
PDMR Transaction Notification
04 Mar 2021 06:17 PM
RNS
PDMR/PCA Transaction Notification
03 Mar 2021 01:40 PM
RNS
Investor Presentation
01 Mar 2021 07:00 AM
RNS
Publication of Circular and Notice of GM
26 Feb 2021 04:09 PM
RNS
Successful completion of £25 million Fundraise
26 Feb 2021 12:30 PM
RNS
Total Voting Rights Update
26 Feb 2021 11:05 AM
RNS
Second Price Monitoring Extn
26 Feb 2021 11:00 AM
RNS
Price Monitoring Extension
26 Feb 2021 09:30 AM
RNS
Placing and Subscription to raise up to £25m
19 Feb 2021 11:05 AM
RNS
Second Price Monitoring Extn
19 Feb 2021 11:00 AM
RNS
Price Monitoring Extension
02 Feb 2021 08:00 AM
EQS
Shield Therapeutics (STX): Beefing up for the U...
29 Jan 2021 02:38 PM
RNS
Shareholder loan facilities

Shield Therapeutics is a pharmaceutical company that develops medicines to treat iron deficiency.

Shield Therapeutics share price is listed on LSE under the ticker STX.

UK 100

Latest directors dealings